Pyott David E I is a director of Pliant Therapeutics Inc.
Person profile
Roles
Address
Irvine, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ALNYLAM PHARMACEUTICALS, INC.
20 May 24
4
PLIANT THERAPEUTICS, INC.
8 Jun 23
4
BIOMARIN PHARMACEUTICAL INC
24 May 23
4
ALNYLAM PHARMACEUTICALS, INC.
19 May 23
4
ALNYLAM PHARMACEUTICALS, INC.
27 Feb 23
4
PLIANT THERAPEUTICS, INC.
21 Jun 22
4
BIOMARIN PHARMACEUTICAL INC
26 May 22
4
ALNYLAM PHARMACEUTICALS, INC.
20 May 22
4
ALNYLAM PHARMACEUTICALS, INC.
25 Feb 22
4
ALNYLAM PHARMACEUTICALS, INC.
19 Jul 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 May 24 | ALNY Alnylam Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 151.22 | 5,228 | 790.58 k | 5,228 |
7 Jun 23 | PLRX Pliant Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 23.09 | 14,000 | 323.26 k | 14,000 |
23 May 23 | BMRN Biomarin Pharmaceutical Inc. - Registered Shares | Common Stock | Grant | Acquire A | No | No | 0 | 4,190 | 0.00 | 45,030 |
18 May 23 | ALNY Alnylam Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 189.87 | 3,454 | 655.81 k | 3,454 |
23 Feb 23 | ALNY Alnylam Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 136 | 0.00 | 136 |
23 Feb 23 | ALNY Alnylam Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 136 | 0.00 | 0 |